Advertisement
Screener

Myomo, Inc. (MYO) Depreciation Expense on Reclassified Assets

2.7 / 5 stars · 45/84 Roast Me

Myomo, Inc. Depreciation Expense on Reclassified Assets

Myomo, Inc. (MYO) reported Depreciation Expense on Reclassified Assets of $859.40 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:DepreciationExpenseOnReclassifiedAssets · last filed 2026-03-09

  • Myomo, Inc. depreciation expense on reclassified assets for fiscal 2025 was $859.40K, a 317.39% increase from fiscal 2024.
  • Myomo, Inc. depreciation expense on reclassified assets for fiscal 2024 was $205.90K, a 25.32% increase from fiscal 2023.
  • Myomo, Inc. depreciation expense on reclassified assets for fiscal 2023 was $164.30K, a 14.78% decline from fiscal 2022.
  • Myomo, Inc. depreciation expense on reclassified assets for fiscal 2022 was $192.80K, a 32.05% increase from fiscal 2021.
Period endDepreciation Expense on Reclassified Assets 12 month
2025-12-31$859.40K
10-K · filed 2026-03-09
2024-12-31$205.90K
10-K · filed 2026-03-09
2023-12-31$164.30K
10-K · filed 2025-03-10
2022-12-31$192.80K
10-K · filed 2024-03-08
2021-12-31$146.00K
10-K · filed 2023-03-13
2020-12-31$105.40K
10-K · filed 2022-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
Safe Pro Group Inc. (SPAI)United States$0.090B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B
Lifeward Ltd. (LFWD)$0.021B
Conexeu Sciences Inc. (CNXU)United States$0.111B
ENvue Medical, Inc. (FEED)United States$0.011B
Bone Biologics Corp (BBLG)United States$0.001B